# Paul Nathan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/paul-nathan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,057 |
| Field | Melanoma and MAPK Pathways |
| h-index | 70 |
| i10-index | 212 |
| Last Known Institution | Mount Vernon Hospital |
| OpenAlex ID | https://openalex.org/A5085499539 |
| ORCID iD | https://orcid.org/0000-0002-2327-3250 |
| Works | 461 |

## Researcher papers

- [Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma](https://scholariq.org/papers/pazopanib-versus-sunitinib-in-metastatic-renal-cell-carcinoma/)
- [Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma](https://scholariq.org/papers/overall-survival-benefit-with-tebentafusp-in-metastatic-uveal-melanoma/)
- [European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023](https://scholariq.org/papers/european-consensus-based-interdisciplinary-guideline-for-diagnosis-and-treatment/)
- [Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma](https://scholariq.org/papers/three-year-overall-survival-with-tebentafusp-in-metastatic-uveal-melanoma/)
- [ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee](https://scholariq.org/papers/esmo-consensus-conference-recommendations-on-the-management-of-metastatic/)
- [Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial](https://scholariq.org/papers/quality-of-life-in-patients-with-advanced-renal-cell-carcinoma-given-nivolumab/)

## Researcher topics

- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Researcher university

- [Mount Vernon Hospital](https://scholariq.org/institutions/mount-vernon-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.